Endava plc (NYSE:DAVA) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lowered its stake in shares of Endava plc (NYSE:DAVAGet Rating) by 8.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 167,146 shares of the company’s stock after selling 14,770 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.30% of Endava worth $13,476,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in DAVA. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Endava by 113.1% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 3,428 shares of the company’s stock worth $456,000 after buying an additional 1,819 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Endava by 61.6% in the 1st quarter. Bank of New York Mellon Corp now owns 2,061 shares of the company’s stock valued at $274,000 after purchasing an additional 786 shares in the last quarter. Cetera Advisor Networks LLC purchased a new stake in Endava in the 1st quarter valued at approximately $363,000. Citigroup Inc. boosted its holdings in Endava by 1,461.2% in the 1st quarter. Citigroup Inc. now owns 10,913 shares of the company’s stock valued at $1,451,000 after purchasing an additional 10,214 shares in the last quarter. Finally, Synovus Financial Corp boosted its holdings in Endava by 32.4% in the 1st quarter. Synovus Financial Corp now owns 9,044 shares of the company’s stock valued at $1,204,000 after purchasing an additional 2,211 shares in the last quarter. Hedge funds and other institutional investors own 52.15% of the company’s stock.

Endava Stock Performance

Shares of DAVA opened at $77.72 on Friday. The stock has a fifty day moving average of $75.50 and a two-hundred day moving average of $84.36. The company has a market capitalization of $4.41 billion, a PE ratio of 37.37 and a beta of 1.17. Endava plc has a fifty-two week low of $61.55 and a fifty-two week high of $146.46.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Morgan Stanley decreased their price target on Endava from $130.00 to $95.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 28th. Susquehanna boosted their price target on Endava from $110.00 to $120.00 in a research note on Wednesday, November 16th. Needham & Company LLC decreased their price target on Endava from $112.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, November 16th. Wedbush decreased their price target on Endava from $120.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, September 28th. Finally, Susquehanna Bancshares lifted their price objective on Endava from $110.00 to $120.00 and gave the stock a “positive” rating in a research report on Wednesday, November 16th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Endava has an average rating of “Moderate Buy” and an average price target of $106.44.

About Endava

(Get Rating)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in Europe, Latin America, North America, and internationally. It offers technology and digital advisory services for payments and financial services, and TMT sectors; IT strategies; business analysis services; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

See Also

Institutional Ownership by Quarter for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.